Johns Hopkins University and Mt. Sinai Hospital of Toronto Honored For Innovative Use of Health Information and Technology to Improve Patient Care
Elsevier ‘Key Innovator Award’ recipients to attend HIMSS13 and present their winning programs at booth #6129
Philadelphia, PA, March 4, 2013 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, has recognized Johns Hopkins University and Mt. Sinai Hospital with the first annual Key Innovator Award for each organization’s innovative use of information and technology to save lives and improve patient care.
Each winning organization received a $10,000 grant and trip to the Healthcare Information Management and Systems Society (HIMSS13) annual meeting in New Orleans, March 3-7. Elsevier’s ClinicalKey, a clinical insight engine that provides the most current and clinically relevant evidence-based answers, sponsored the award.
“We developed the Key Innovator Award to raise awareness of health IT projects that have significantly contributed to improving patient outcomes and exemplify the true meaning of innovation in healthcare,” said Jay Katzen, president of Elsevier’s clinical solutions business. “These winning organizations have created programs that not only improve patient care but exemplify how effectively leveraging technology and information can revolutionize standards of quality healthcare.”
The Key Innovator Award recipients will present their winning projects at HIMSS13 at Elsevier’s booth (#6129). These winners’ programs are:
- Mood 24/7, invented by Dr. Adam Kaplin, an Assistant Professor in the Departments of Psychiatry and Neurology at Johns Hopkins University School of Medicine, is a web-based program that utilizes cell phones and texting technology to send automatic daily texts to a patient at a specified time, asking the patient to record his/her mood. Mood 24/7 was developed to support psychologists’ ability to capture their patients’ moods over time, as patients often forget to maintain the written record between office visits.
- The Evidence-Based Medicine Algorithm, created by Sandra Kendall, Director of Library Services at Mount Sinai Hospital, was developed to demonstrate how the power of information can improve clinicians' work, thus improving patient care. She grouped different databases into tiers, assisting practitioners in choosing the best evidence-based resources available. Kendall also recently created a Library Value Study designed to demonstrate how the library has contributed to better medical education and clinical research, and to seek input into how the library can continue to contribute to better patient care by supporting clinical research in innovative ways.
“On behalf of the team at Mt. Sinai in Toronto, we are very excited to receive this award from Elsevier,” Kendall said. “We see tremendous value in the evidence-based medicine project, as it allows our physicians to fully leverage the power of our resources in ways that they haven’t done before to directly influence patient care delivery.”
Elsevier will host a Meet & Greet for the Key Innovator Award winners at HIMSS13. To learn more about their projects, please visit booth #6129 on:
- Monday, March 4, 2-3 p.m. – Johns Hopkins
- Tuesday, March 5, 10:30-11:30 a.m. – Mount Sinai Hospital
In addition to recognizing the Key Innovator Award winners, Elsevier will demonstrate its integrated clinical decision support (CDS) and clinical reference solutions that help healthcare providers and payers achieve the triple aim of clinical, operational and financial excellence.
Learn more about Elsevier, ClinicalKey and the Key Innovator Award honorees at HIMSS13, March 3-7, in New Orleans at booth #6129. For a full schedule of Elsevier product demonstrations and presentations at HIMSS13, please visit www.clinicaldecisionsupport.com/himss13.
# # #About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations
+1 212 633 3164